Abstract
Aim:
Diabetes is associated with elevated serum total cholesterol level and disrupted lipoprotein subfractions. The aim of this study was to examine alterations in the tissue cholesterol contents closely related to diabetic complications.
Methods:
Intraperitoneal injection of streptozotocin was used to induce type 1 diabetes in adult male Sprague-Dawley rats. On d 35 after the injection, liver, heart, intestine, kidney, pancreas, cerebral cortex and hippocampus were isolated from the rats. The content of total and free cholesterol in the tissues was determined using HPLC. The ATP-binding cassette protein A1 (ABCA1) protein and ApoE mRNA were measured using Western blot and QT-PCR analyses, respectively.
Results:
In diabetic rats, the level of free cholesterol was significantly decreased in the peripheral tissues, but significantly elevated in hippocampus, as compared with those in the control rats. Diabetic rats showed a trend of decreasing the total cholesterol level in the peripheral tissues, but significant change was only found in kidney and liver. In diabetic rats, the level of the ABCA1 protein was significantly increased in the peripheral tissues and cerebral cortex; the expression of ApoE mRNA was slightly decreased in hippocampus and cerebral cortex, but the change had no statistical significance.
Conclusion:
Type 1 diabetes decreases the free cholesterol content in the peripheral tissues and increases the free cholesterol content in hippocampus. The decreased free cholesterol level in the peripheral tissues may be partly due to the increased expression of the ABCA1 protein.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, et al. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 2005; 28: 1051–6.
Miyazaki A, Sakashita N, Lee O, Takahashi K, Horiuchi S, Hakamata H, et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler Thromb Vasc Biol 1998; 18: 1568–74.
Paulson KE, Zhu S-N, Chen M, Nurmohamed S, Jongstra-Bilen J, Cybulsky MI . Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 2010; 106: 383–90.
Jun JY, Ma Z, Segar L . Spontaneously diabetic Ins2+/Akita: apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis. Am J Physiol Endocrinol Metab 2011; 301: E145–54.
James SH, Meyers AM . Microangiopathic hemolytic anemia as a complication of diabetes mellitus. Am J Med Sci 1998; 315: 211–5.
Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J . Total cholesterol and the risk of Parkinson disease. Neurology 2008; 70: 1972–9.
Hartmann T . Cholesterol, Aβ and Alzheimer's disease. Trends Neurosci 2001; 24: S45–8.
Luo DX, Cao DL, Xiong Y, Peng XH, Liao DF . A novel model of cholesterol efflux from lipid-loaded cells. Acta Pharmacol Sin 2010; 31: 1243–57.
Calkin AC, Forbes JM, Smith CM, Lassila M, Cooper ME, Jandeleit-Dahm KA, et al. Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arterioscler Thromb Vasc Biol 2005; 25: 1903–9.
Tang C, Kanter JE, Bornfeldt KE, Leboeuf RC, Oram JF . Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res 2010; 51: 1719–28.
Dong J, Chen W, Wang S, Zhang J, Li H, Guo H, et al. Jones oxidation and high performance liquid chromatographic analysis of cholesterol in biological samples. J Chromatogr B 2007; 858: 239–46.
Abell LL, Levy BB, Brodie BB, Kendall FE . A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357–66.
Honda A, Yamashita K, Hara T, Ikegami T, Miyazaki T, Shirai M, et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J Lipid Res 2009; 50: 350–7.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001; 25: 402–8.
Liu H, Xu X, Yang Z, Deng Y, Liu X, Xie L . Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res 2006; 1123: 245–52.
Oram JF, Lawn RM, Garvin MR, Wade DP . ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000; 275: 34508–11.
Li D, Wang D, Wang Y, Ling W, Feng X, Xia M . Adenosine monophosphate activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in Apolipoprotein E-deficient mice. J Biol Chem 2010; 285: 33499–509.
Rahman SMA, Van Dam AM, Schultzberg M, Crisby M . High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. J Neuroimmunol 2005; 169: 59–67.
Vance JE, Hayashi H . Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta 2010; 1801: 806–18.
Hayashi H . Lipid metabolism and glial lipoproteins in the central nervous system. Biol Pharm Bull 2011; 34: 453–61.
Lane RM, Farlow MR . Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 2005; 46: 949–68.
Wilson JD . The measurement of the exchangeable pools of cholesterol in the baboon. J Clin Invest 1970; 49: 655–65.
Dell RB, Mott GE, Jackson EM, Ramakrishnan R, Carey KD, McGill HC, et al. Whole body and tissue cholesterol turnover in the baboon. J Lipid Res 1985; 26: 327–37.
Prince PSM, Kannan NK . Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. J Pharm Pharmacol 2006; 58: 1373–83.
Geethan PK, Prince PS . Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic wistar rats. J Biochem Mol Toxicol 2008; 22: 220–4.
Sarkar C, Cenedella R . Reactivity of key metabolic sterols in standard colorimetric assays for cholesterol. Lipids 1982; 17: 46–9.
Morris TG . A comparison of methods for the estimation of serum cholesterol and values in random samples of populations in the 55-64 age group. J Clin Path 1959; 12: 518–23.
Uehara Y, Engel T, Li Z, Goepfert C, Rust S, Zhou X, et al. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 2002; 51: 2922–8.
Shen L, Tso P, Woods SC, Clegg DJ, Barber KL, Carey K, et al. Brain Apolipoprotein E: an important regulator of food intake in rats. Diabetes 2008; 57: 2092–8.
Lenich CM, Chobanian AV, Brecher P, Zannis VI . Effect of dietary cholesterol and alloxan-diabetes on tissue cholesterol and apolipoprotein E mRNA levels in the rabbit. J Lipid Res 1991; 32: 431–8.
Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab 2010; 12: 567–79.
Russell DW, Halford RW, Ramirez DMO, Shah R, Kotti T . Cholesterol 24-hydroxylase: An enzyme of cholesterol turnover in the brain. Annu Rev Biochem 2009; 78: 1017–40.
Kamboj SS, Chopra K, Sandhir R . Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation. Neuroscience 2009; 162: 349–58.
Nonomura K, Arai Y, Mitani H, Abe-Dohmae S, Yokoyama S . Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation. Atherosclerosis 2011; 216: 334–41.
Gerin I, Dolinsky VW, Shackman JG, Kennedy RT, Chiang S-H, Burant CF, et al. LXRβ is required for adipocyte growth, glucose homeostasis, and β cell function. J Biol Chem 2005; 280: 23024–31.
Huang TH-W, Razmovski-Naumovski V, Salam NK, Duke RK, Tran VH, Duke CC, et al. A novel LXR-α activator identified from the natural product Gynostemma pentaphyllum. Biochem Pharmacol 2005; 70: 1298–308.
Tamehiro N, Sato Y, Suzuki T, Hashimoto T, Asakawa Y, Yokoyama S, et al. Riccardin C: A natural product that functions as a liver X receptor (LXR)α agonist and an LXRβ antagonist. FEBS Lett 2005; 579: 5299–304.
Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999; 274: 35832–9.
Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F . SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004; 86: 839–48.
Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL . Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 1999; 96: 13656–61.
Schiefelbein D, Goren I, Fisslthaler B, Schmidt H, Geisslinger G, Pfeilschifter J, et al. Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses. J Biol Chem 2008; 283: 15479–90.
Easom RA, Zammit VA . Effects of diabetes on the expressed and total activities of 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver in vivo. Reversal by insulin treatment. Biochem J 1985; 230: 747–52.
Ravid Z, Bendayan M, Delvin E, Sane AT, Elchebly M, Lafond J, et al. Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors. Am J Physiol Gastrointest Liver Physiol 2008; 295: G873–85.
Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M . Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006; 55: 2502–9.
Zhao C, Dahlman-Wright K . Liver X receptor in cholesterol metabolism. J Endocrinol 2010; 204: 233–40.
Zager RA . Plasma membrane cholesterol: A critical determinant of cellular energetics and tubular resistance to attack. Kidney Int 2000; 58: 193–205.
Wang H, Xie X, Zhang F, Zhou Q, Tao Q, Zou Y, et al. Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivatives. Food Chem Toxicol 2011; 49: 1387–93.
Tsujikawa H, Song Y, Watanabe M, Masumiya H, Gupte SA, Ochi R, et al. Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its β-adrenergic enhancement in ventricular myocytes. Am J Physiol Heart Circ Physiol 2008; 294: H285–92.
Sones WR, Davis AJ, Leblanc N, Greenwood IA . Cholesterol depletion alters amplitude and pharmacology of vascular calcium-activated chloride channels. Cardiovasc Res 2010; 87: 476–84.
Balut C, Steels P, Radu M, Ameloot M, Driessche WV, Jans D . Membrane cholesterol extraction decreases Na+ transport in A6 renal epithelia. Am J Physiol Cell Physiol 2006; 290: C87–94.
Hao M, Head WS, Gunawardana SC, Hasty AH, Piston DW . Direct effect of cholesterol on insulin secretion. Diabetes 2007; 56: 2328–38.
Larsson S, Wierup N, Sundler F, Eliasson L, Holm C . Lack of cholesterol mobilization in islets of hormone-sensitive lipase deficient mice impairs insulin secretion. Biochem Biophys Res Commun 2008; 376: 558–62.
Hao M, Bogan JS . Cholesterol regulates glucose-stimulated insulin secretion through phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2009; 284: 29489–98.
Acknowledgements
This work was supported by the National Science Foundation of China (Grants No 30873123 and 39970862) and the Funding for Innovative Research Team in the Institution of Jiangsu Higher Education.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Xt., Li, J., Liu, L. et al. Tissue cholesterol content alterations in streptozotocin-induced diabetic rats. Acta Pharmacol Sin 33, 909–917 (2012). https://doi.org/10.1038/aps.2012.50
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2012.50
Keywords
This article is cited by
-
Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Molecular Neurobiology (2013)
